KOMBITEST CD3 FITC / CD16 + CD56 PE / CD45 PerCP / CD19 APC

KOMBITEST CD3 FITC / CD16 + CD56 PE / CD45 PerCP / CD19 APC
Regulatory status
CE IVD
Format
Conjugate mixture
Reactivity
Human
Application
FC (QC tested)
Variant
50 tests
ED7074
In stock
0.00 USD
Variant
0.1 mg
11-261-C100
In stock
0.00 USD
Product details
References
Application
FC (QC tested)
Reactivity
Human
Description
The KOMBITEST CD3 FITC / CD16+CD56 PE / CD45 PerCP / CD19 APC is designed for identification and enumeration of human T, natural killer and B lymphocytes in erythrocyte-lysed whole blood using flow cytometry.
Contents
The reagent contains a premixed combination of mouse monoclonal antibody against human CD3 antigen (clone UCHT1) labeled with fluorescein isothiocyanate (FITC), mouse monoclonal antibody against human CD16 antigen (clone 3G8) labeled with R-phycoerythrin (PE), mouse monoclonal antibody against human CD56 antigen (clone LT56) labeled with R phycoerythrin (PE), mouse monoclonal antibody against human CD45 antigen (clone MEM-28) labeled with peridinin-chlorophyll-protein complex (PerCP), and mouse monoclonal antibody against human CD19 antigen (clone LT19) labeled with allophycocyanin (APC). Labeled antibodies are diluted at optimum concentration in stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide. The content of a vial (1 ml) is sufficient for 50 tests.
Preparation
Premixed combination of mouse monoclonal antibodies labeled with different fluorochromes and diluted in optimal concentrations in stabilizing buffer
Formulation
Stabilizing phosphate buffered saline (PBS) solution containing 15mM sodium azide
Storage and handling
Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light. Do not use after expiration date stamped on vial label.
Exbio licence note
The product is intended for In Vitro Diagnostic Use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Product specific references:

Holubová M, Leba M, Gmucová H, Caputo VS, Jindra P, Lysák D: Improving the Clinical Application of Natural Killer Cells by Modulating Signals Signal from Target Cells. Int J Mol Sci. 2019 Jul 15;20(14). pii: E3472.
PubMed
Variant
50 tests
ED7074
In stock
0.00 USD
Variant
0.1 mg
11-261-C100
In stock
0.00 USD